Sight Sciences Inc investor relations material
Sight Sciences, Inc. engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists; and Dermacare AC System, a non-steroidal skin cancer therapy for dermatologists. It offers its products through sales representatives and distributors to hospitals, medical centers, eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.